Skip to content
Recall Observatory FDA recall evidence

Drug product

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

D-0552-2026

May 18, 2026

Class III

Product summary

Firm
Eugia US LLC
Event
Event 99024
Status
Ongoing
Classification
Class III
Quantity
168,300 vials
Official record key
drug-enforcement:D-0552-2026

Official wording

Reason: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Code information: Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029

Distribution pattern: US Nationwide.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan